arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Scienture Holdings, Inc.

SCNX
$0.37 0.00 (-0.08%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
14 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

Scienture Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $5.7M
Dividend Yield
Revenue Growth 215.9%
Op. Margin None
ROIC -58.0%
FCF / Share $-0.87
Trailing P/E
Price / Book 0.2x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$431.61K
↑ +215.9%
Net Income Profit after all expenses
$-41.51M
↓ -557.9%
Operating Margin Operating profit as % of sales
-87.8%
↓ -127.2%
FCF / Share Free cash flow per share
$-0.87
↑ +79.4%
Long-Term Debt Long-term obligations
$2.90M
↑ +1187.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
14
Cash Quality
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 54 quarters